Clinical Trials Logo

Clinical Trial Summary

This research study is evaluating the impact of early involvement of a palliative care team working with the transplant oncology team will have on the quality of life, symptoms, and mood of patients undergoing stem cell transplantation.


Clinical Trial Description

The Participant has a type of blood cancer and will be undergoing stem cell transplantation. Frequently people undergoing stem cell transplantation experience physical and emotional symptoms during the course of their hospitalization for stem cell transplantation. These can be very distressing to both patient and the family members. The study doctors want to know if the early introduction of a team of clinicians that specialize in the lessening (palliation) of many of these distressing symptoms may improve the participant overall care. This team of clinicians is called the palliative care team and they focus on ways to improve the participant pain and other symptom management (nausea, fatigue, shortness of breath, anxiety, etc.) and to assist the participant and the participant's family in coping with the emotional and social issues associated with your diagnosis. The team consists of physicians and advance practice nurses who have been specially trained in the care of patients facing serious illness. The main purpose of this study is to compare two types of care - standard transplant oncology care and standard transplant oncology care with early involvement of palliative care clinicians to see which is better for improving the experience of patients and families with blood cancers undergoing stem cell transplantation. The purpose of this research study is to find out whether introducing patients and families undergoing stem cell transplantation to the palliative care team that specializes in symptom management can improve the physical and psychological symptoms that patients and families experience during hospitalization for stem cell transplantation. The study will use a series of questionnaires to measure the participant and the participant 's caregivers' quality of life, physical symptoms, and mood. Study questionnaires will be completed in the hospital or clinic with assistance provided as need. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03641378
Study type Interventional
Source Massachusetts General Hospital
Contact
Status Completed
Phase N/A
Start date September 30, 2018
Completion date July 1, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT06155188 - Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia N/A
Recruiting NCT03562065 - Treatment of Refractory Systemic Lupus Erythematosus by Allogeneic Mesenchymal Stem Cells Derived From the Umbilical Cord Phase 1/Phase 2
Completed NCT01468935 - Bone Marrow Cell Engraftment of the Uterus and Genetic Studies of Reproductive Functioning
Active, not recruiting NCT03938324 - Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions N/A
Completed NCT04219657 - Comparison Between Skin Graft Versus Skin Graft and Stem Cell Application Phase 1
Not yet recruiting NCT03259217 - Clinical Application of Mesenchymal Stem Cells Seeded in Chitosan Scaffold for Diabetic Foot Ulcers Phase 1
Recruiting NCT01189786 - Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection N/A
Recruiting NCT04610359 - Safety of Human Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells in Interstitial Cystitis Phase 1
Completed NCT05712148 - Spheroidal Mesenchymal Stem Cells in Retinitis Pigmentosa Phase 1/Phase 2
Recruiting NCT05515497 - BMT4me: Post-HSCT Medication Adherence mHealth App N/A
Completed NCT01984671 - Mobile Pain Coping Skills Training for Stem Cell Transplant Patients N/A
Not yet recruiting NCT06075927 - Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCT Phase 1/Phase 2
Completed NCT03440775 - Digital Stories and Psychosocial Wellbeing in Stem Cell Transplant Patients N/A
Recruiting NCT02652052 - Hematopoietic Stem Cell Transplant Survivors Study N/A
Not yet recruiting NCT04922970 - Strength Training as Prevention and Treatment of Late Effects in Long-term Survivors of Pediatric HSCT. N/A
Completed NCT01092195 - Gardasil Vaccination in Post Stem Cell Transplant Patients Phase 1
Completed NCT04041219 - Use of Sublingual Tacrolimus in Adult Blood and Marrow Transplant Patients Phase 4
Completed NCT00656058 - Montelukast to Treat Bronchiolitis Obliterans Phase 2
Recruiting NCT04375579 - Assessment of Elderly Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Completed NCT03859765 - In Person and mHealth Coping Skills Training for Symptom Management and Steps in Stem Cell Transplant Patients N/A